CrossrefInfokarte
Durvalumab and bevacizumab plus transarterial chemoembolization in unresectable hepatocellular carcinoma: a new paradigm?
Translational Gastroenterology and Hepatology · 2026-01 · 11 · 1-1
DOI: 10.21037/tgh-25-34 ↗Abstract
Kein Abstract verfügbar.
EUVIMED